Projects per year
Fingerprint
Dive into the research topics where Raymond Borrow is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Safety and immunogenicity of nasal inoculation with recombinant Neisseria lactamica expressing Factor H binding protein and Neisseria Adhesin A.
Laver, J. R. (PI), Lucidarme, J. (CoPI), Dale, A. P. (CoPI), Gorringe, A. (CoPI), Faust, S. N. (CoPI), Cleary, D. (CoPI), Read, R. C. (CoPI) & Borrow, R. (CoPI)
1/05/24 → 30/04/29
Project: Research
-
The dynamics of meningococcal carriage in Africa and the impact of vaccination.
Greenwood, B. (PI), Borrow, R. (CoPI), LaForce, F. M. (CoPI) & Maiden, M. C. J. (CoPI)
8/01/09 → 31/12/12
Project: Research
-
Ability of the MenB-fHbp vaccine to provide immune protection against meningococcal serogroup B ST-1161 UK university “South West Outbreak” strain isolates
Lucidarme, J., Clark, S. A., Borrow, R., Murthy, A. K., Tan, C., Naqvi, R., Ladhani, S. N. & Findlow, J., 30 Apr 2026, In: Vaccine. 80, 128503.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Do the protein-based meningococcal group B vaccines, 4CMenB and MenB-fHbp, elicit serum bactericidal antibody against meningococcal serogroup X clonal complex 181?
Townsend-Payne, K., Hill, E., Ali, H., Mabey, L., Clark, S. A., Basta, N. E., Linley, E. & Borrow, R., Aug 2026, In: International Journal of Infectious Diseases. 169, 108752.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023
Foster, K., Heymer, E. J., Campbell, H., Wilson, E., Baldasera, J., Lucidarme, J., Clark, S. A., Bai, X., Ahmad, S., Borrow, R. & Ladhani, S. N., 22 Jan 2026, In: Eurosurveillance. 31, 3Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial
Thorn, N., Danos, Z., Andrews, N. J., Sutton, N., Cathie, K., Owens, D., Kelly, D., Shackley, F., Scorrer, T., Lea, C., Collinson, A., Miah, T., Lewis-Bridgeman, J., Pearce, J., Borrow, R., Louth, J., Bell, A., Ladhani, S. N. & Heath, P. T., 6 May 2026, In: The Lancet Infectious Diseases. 26, 8, p. 793-806 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Immunogenicity and safety of two doses of the four-component recombinant meningococcal B (4CMenB) vaccine in adults with immunodeficiency
Sticchi, L., Di Biagio, A., Domnich, A., Inglese, M., Mikulska, M., Louth, J., Borrow, R., Di Grazia, C., Lapucci, C., Bassetti, M. & Icardi, G., 19 Mar 2026, In: Vaccine. 76, 128295.Research output: Contribution to journal › Article › peer-review
Open Access